This is a routine Form 3 filing for a new officer with no disclosed holdings. No trading signal. Monitor future Form 4 filings for any open-market purchases or sales by Hollander, which would provide insider sentiment data.
Price Chart
Executive Summary
David Hollander filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing his role as Chief R&D Officer of Veradermics, Inc. (MANE). The filing is a routine administrative requirement for a new officer and includes a limited power of attorney authorizing Michael Greco and Erika Sipperly to execute future Section 16 filings on his behalf. No beneficial ownership amounts or securities transactions are disclosed in the filing, making this a non-event for stock price impact.
Key Facts
- David Hollander filed a Form 3 as a new insider of Veradermics, Inc.
- Hollander's title is Chief R&D Officer.
- The filing includes a limited power of attorney for Michael Greco and Erika Sipperly to handle future Section 16 filings.
- No beneficial ownership amounts or securities transactions are reported in the filing.
Financial Impact
No financial impact — the filing is a routine initial ownership statement with no disclosed holdings or transactions.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (MANE) — Batch item 1 | 0001628280-26-058305 |
| Document: 0001628280-26-058305-index-headers.html | 0001628280-26-058305 |
| Document: 0001628280-26-058305-index.html | 0001628280-26-058305 |
| Document: 0001628280-26-058305.txt | 0001628280-26-058305 |
| 3 Filing (MANE) — Batch item 5 | 0001628280-26-058305 |
| Document: 0001628280-26-058305-index-headers.html | 0001628280-26-058305 |
| Document: 0001628280-26-058305-index.html | 0001628280-26-058305 |
| Document: 0001628280-26-058305.txt | 0001628280-26-058305 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $122.28 | awaiting T+5 | — | $139.19 (+13.83%) |
Oct 13, 2026 12d ago | SC 13G | $116.26 $127.11 | ▲ +9.33% | ▲ +10.48% | $139.19 (+19.72%) |
Aug 21, 2026 9w ago | Insider Cluster | $98.46 $98.41 | ▲ +0.05% | ▲ +0.52% | $139.19 (−41.37%) |
Aug 20, 2026 9w ago | 3 | $102.82 $97.93 | ▼ −4.76% | ▼ −5.23% | $139.19 (+35.37%) |
Aug 18, 2026 9w ago | Insider Cluster | $111.23 $102.80 | ▼ −7.58% | ▼ −7.19% | $139.19 (+25.14%) |
Aug 11, 2026 10w ago | 8-K | $110.75 $111.31 | ▲ +0.51% | ▲ +0.91% | $139.19 (+25.68%) |
Aug 7, 2026 11w ago | S-1 | $110.75 $108.22 | ▲ +2.28% | ▲ +2.24% | $139.19 (−25.68%) |
Aug 7, 2026 11w ago | Institutional Cluster | $114.39 $112.71 | ▼ −1.47% | ▼ −1.87% | $139.19 (+21.68%) |
Jul 15, 2026 14w ago | 8-K | $123.70 $109.85 | ▼ −11.20% | ▼ −10.22% | $139.19 (+12.52%) |
May 12, 2026 23w ago | 8-K | $103.90 $100.38 | ▼ −3.39% | ▼ −3.47% | $139.19 (+33.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers